| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.046 | 0.8 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |